(Q33726756)

28 July 2017

title

Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study (English)

1 reference

28 July 2017

main subject

angiogenesis inhibitor

1 reference

1

Lorelei A Mucci

1 reference

28 July 2017

4

Fredrick Schumacher

1 reference

28 July 2017

11

Philip W Kantoff

1 reference

28 July 2017

8

Meir J Stampfer

1 reference

28 July 2017

2

Jennifer R Stark

1 reference

28 July 2017

6

Miyako Abe

1 reference

28 July 2017

William D Figg

3

1 reference

28 July 2017

Haojie Li

5

1 reference

28 July 2017

Kristen Hennessy

7

1 reference

28 July 2017

John Michael Gaziano

9

1 reference

28 July 2017

Jing Ma

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

International Journal of Cancer

28 July 2017

published in

1 reference

28 July 2017

volume

125

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

1143-1146

1 reference

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate [corrected] cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Fundamental Concepts of the Angiogenic Process

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Role of angiogenesis in tumor growth and metastasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Adipose tissue mass can be regulated through the vasculature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Lack of collagen XVIII/endostatin results in eye abnormalities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Tumor angiogenesis: therapeutic implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Genotyping and functional analysis of the D104N variant of human endostatin

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.24423

Angiogenic factors are elevated in overweight and obese individuals.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Body mass index and risk of prostate cancer in U.S. health professionals

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838373

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19431146

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Endostatin induces endothelial cell apoptosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19431146

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/IJC.24423

1 reference

28 July 2017

1 reference

28 July 2017

1 reference